
Aug 23, 2022
FSHD Clinical Trial Research Network Quarterly Newsletter - Summer 2022

Aug 23, 2022
CMS has accepted a formal request to consider both the benefit category and coverage for seat elevation systems and standing systems.

Aug 4, 2022
Dr. Sanchez provides a final update on his novel tongue EIM assessment device.

Aug 4, 2022
Final udpate from Dr Guo on the generation of a craniofacial muscle model of FSHD from iPSCs.

Aug 4, 2022
Dr. Ozes provides a brief update on progress in testing quite novel DUX4 inhibitors.

Connect with us on social media